TAXUS^® Liberté^® Long Paclitaxel-Eluting Coronary Stent System

Advancing Stent Design for Drug Delivery in Long Lesions

Engineered for Consistent Drug Distribution

• Unique, uniform repeating cell geometry supports even drug distribution and delivery
• Hybrid cell design allows for strength, flexibility and conformability

Designed for Improved Deliverability in Long Lesions

• 27% thinner struts (0.0038")¹
• Low stent crossing profile (0.046")
• Lowest tip profile (0.017")
• 10% more trackable stent delivery system¹

Improved Stent Apposition and Uniform Neointimal Coverage

• 25% more uniform neointimal coverage and improved stent apposition²
• Consistent low levels of neointimal volume

*Computer modeling of drug distribution uniformity in vascular tissue. Modeling results are for demonstration purposes only and may not necessarily be indicative of clinical performance. Testing completed by Boston Scientific Corporation. Data on file.
¹ As compared to the TAXUS® Express²® Stent System. Testing completed by Boston Scientific Corporation. Data on file.
² As compared to the TAXUS Express Stent System from the TAXUS ATLAS Trial.

Advancing Safety in Long Lesions

*Using the same inclusion criteria (lesions ≥26mm and ≤34mm), a significantly higher percentage of patients in the TAXUS Express Stent control arm required multiple stents to cover the lesion.

In the TAXUS ATLAS Long Lesion Trial, the primary endpoint was met, with a statistically significantly lower 9-month analysis segment Percent Diameter Stenosis for the TAXUS Liberté Long Stent versus the TAXUS Express Stent control (31.65% ± 17.24% versus 32.57% ± 19.28%, p=0.0010).

Product Information

The C-code used for the TAXUS Liberté Long Stent is C1874: Stent, coated/covered, with delivery system. C-codes are used for hospital outpatient device reporting for Medicare and some private payers.

Note: Boston Scientific is not responsible for the correct use of codes on submitted claims; this information does not constitute reimbursement or legal advice.

All claims based on bench test data. Testing completed by Boston Scientific Corporation. Data on file. Bench test results not necessarily indicative of clinical performance.